HCPCS Level II code L8684 designates an external radiofrequency transmitter used with an implantable sacral root neurostimulator receiver for bowel and bladder management, specifically for replacement of the external transmitter. This code matters nationally as sacral neuromodulation is an established therapy for refractory urinary and fecal dysfunction, and accurate device coding supports appropriate supply tracking, billing, and device lifecycle management across payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of what L8684 represents clinically and operationally, typical places of service, and which payers commonly adjudicate claims for external neurostimulation transmitters. The publication also highlights benchmarks and billing considerations tied to device replacement claims, summarizes relevant policy themes affecting coverage of implantable neuromodulation system components, and provides clinical context on the role of external transmitters in sacral neuromodulation therapy.

This executive summary equips billing staff, DME suppliers, and health policy stakeholders with concise guidance on the code’s purpose, payer landscape, and areas to examine when preparing and auditing claims for external sacral neurostimulator transmitters.